Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 12, 1997, Pages 1075-1080

  Ishibe, Naoko ^a   Wiencke, John K ^b   Zuo, Zheng Fa ^a   McMillan, Alex ^b   Spitz, Margaret ^c   Kelsey, Karl T ^a,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d Department of Cancer Biology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENETIC POLYMORPHISM; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; NEGRO; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MEXICAN AMERICANS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; SMOKING; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 0031440755     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. American Cancer Society. Cancer Facts and Figures. Atlanta: American Cancer Society Inc., 1996.
2. Shimada, T., Yun, C. H., Yamazaki, H., Gautier, J. C., Beaune, P. H., and Guengerich, F. P. Characterization of human lung microsomal cytochrome P450 1A1 and its role in oxidation of chemical carcinogens. Mol. Pharmacol., 41: 856-864, 1992.
3. McManus, M. E., Burgess, W. M., Veronese, M. E., Huggett, A., Quattrochi, L. C., and Tukey, R. H. Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochrome P450. Cancer Res., 50: 3367-3376, 1990.
4. Kellerman, G., Shaw, C. R., and Luyten-Kellerman, M. Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N. Engl. J. Med., 289: 934-937, 1974.
5. Kawajiri, K., Nakachi, K., Imai, K., Yoshii, A., Shinoda, N., and Watanabe, J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEES Lett., 263: 131-133, 1990.
6. Hayashi, S., Watanabe, J., Nakachi, K., and Kawajiri, K. Genetic linkage of lung cancer-associated MspI polymorphism with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J. Biochem., 110: 407-411, 1991.
7. Cascorbi, I., Brockmoller, J., and Roots, I. A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res., 56: 4965-4969, 1996.
8. Crofts, F., Cosma, G., Currie, D., Taioli, E., Toniolo, P., and Garte, S. J. A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis (Lond.), 14: 829-831, 1993.